Health In Tech, Inc. logo

Health In Tech, Inc.

HIT

NASDAQTechnologySoftware - Application

Previous close

$1.00

−$0.02 · -1.96%

Aug 21, 4:00 PM ET

HIT company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

51

Fair Value

Momentum

22

Weakening

Sentiment

59

Mixed

Risk resilience

12

Extreme Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Health In Tech, Inc. operates as a cutting-edge insurance technology provider. The company delivers a range of specialized insurance solutions for smaller enterprises, such as value-based pricing strategies, group insurance captives, localized community health plans, and collective association health programs. Additionally, it offers the enhanced "do it yourself" benefit system (eDIYBS), a cloud-based SaaS platform engineered to efficiently generate health insurance quotes for small to medium-sized businesses. Health In Tech further supports healthcare administration with its "health intelligence" (HI) card, which streamlines the management of medical records and claims. Complementing this is the HI performance network, an extensive series of medical facilities that utilize Medicare-based reimbursement pricing. This organization was established in 2014 and its principal offices are located in Stuart, Florida.

Industry
Software - Application
Sector
Technology
Headquarters
US
CEO
Tim Johnson
Listed since
Dec 23, 2024
Employees
89

Market position

Day range

Current $1.00

52-week range

Current $1.00

Open
$0.9906
Previous close
$1.02
Volume
66.8K
0.43× average
Average volume
154.72K
Average daily volume
Market cap
53.86M USD
Beta
2.83
Market reference 1
50-day average
$1.059
-5.57% below average
200-day average
$1.3463
-25.72% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
81.26M USD
P/E (TTM)
-14.18×
P/B (TTM)
3.2×
P/S (TTM)
1.64×
EV / EBITDA
31.56×
Earnings yield
1.44%
Free cash flow yield
-0.06%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
53.93%
Operating margin
-16.07%
Net margin
-12.03%
Return on equity
7.47%
Return on assets
5.54%
Return on invested capital
6.48%

Financial health

Debt / equity
0.01×
Current ratio
3.13×

Earnings

EPS beat rate
14%
1 beat, 3 misses, 3 met estimates
Average EPS surprise
-39.28%
7 comparable reports
Latest EPS result
-0.04
Estimate -0.03 · Miss by 49.98%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.060.01-0.03-0.08Q1 '25MissQ2 '25MissQ3 '25MetQ4 '25MetQ1 '26MetQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Mar 17, 2025: actual -0.01, estimate 0.01, surprise -200.00%, Miss. Q2 2025, reported Apr 14, 2025: actual 0.01, estimate 0.02, surprise -50.00%, Miss. Q3 2025, reported Jul 21, 2025: actual 0.01, estimate 0.01, surprise 0.00%, Met estimate. Q4 2025, reported Nov 10, 2025: actual 0.01, estimate 0.01, surprise 0.00%, Met estimate. Q1 2026, reported Mar 25, 2026: actual -0.01, estimate -0.01, surprise 0.00%, Met estimate. Q2 2026, reported May 13, 2026: actual -0.03, estimate -0.04, surprise +25.00%, Beat. Q3 2026, reported Aug 13, 2026: actual -0.04, estimate -0.027, surprise -49.98%, Miss. Q4 2026, reported Nov 9, 2026: actual —, estimate -0.02, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates12.03M9.51M7M4.48MQ1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 17, 2025: actual 5M USD, estimate 8M USD, surprise -37.50%, Miss. Q2 2025, reported Apr 14, 2025: actual 8.01M USD, estimate 8M USD, surprise +0.09%, Beat. Q3 2025, reported Jul 21, 2025: actual 9.31M USD, estimate 7.49M USD, surprise +24.34%, Beat. Q4 2025, reported Nov 10, 2025: actual 8.49M USD, estimate 7.05M USD, surprise +20.43%, Beat. Q1 2026, reported Mar 25, 2026: actual 7.51M USD, estimate 7.26M USD, surprise +3.37%, Beat. Q2 2026, reported May 13, 2026: actual 8.8M USD, estimate 7.45M USD, surprise +18.11%, Beat. Q3 2026, reported Aug 13, 2026: actual 8.1M USD, estimate 7.78M USD, surprise +4.08%, Beat. Q4 2026, reported Nov 9, 2026: actual —, estimate 11.51M USD, surprise —, Comparison unavailable.

HIT peers

ETFs holding HIT

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research HIT

research.disclaimer